Key mechanosensing signaling molecules such as focal adhesion kinase (FAK), cadherins, integrins, and syndecans were shown to be activated [90,139,140], resulting in modulation of metastatic dissemination, matrix-independent survival and chemotherapeutic resistance of different cancer types [141,142]. The gene discussed is PTK2; the disease is cancer.